Facile synthesis of an azido-labeled thalidomide analogue

Organic Letters

Volumn 5, Issue 16, 2003, Pages 2865-2867

  Capitosti, Scott M ^a   Hansen, Todd P ^a   Brown, Milton L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE DERIVATIVE;

ADDITION REACTION; ARTICLE; BIOAVAILABILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHOTOAFFINITY LABELING; PURIFICATION;

EID: 0141520532     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol034906w     Document Type: Article

References (27)

1. Eriksson, T.; Bjorkman, S.; Hoglund, P. Eur. J. Clin. Pharmacol. 2001, 57, 365.
2. (a) Arora, M.; Wagner, J. E.; Davies, S. M.; Blazar, B. R.; Defor, T.; Enright, H.; Miller, W. J.; Weisdorf, D. F. Biol. Blood Marrow Transplant. 2001, 7 (5), 265.
3. (b) Gaziev, D.; Lucarelli, G. Expert Opin. Investig. Drugs 2001, 10, 5, 909.
4. (a) Teo, S. K.; Resztak, K. E.; Scheffler, M. A.; Kook, K. A.; Zeldis, J. B.; Stirling, D. I.; Thomas, S. D. Microbes Infect. 2002, 4, 1193.
5. (b) Sheskin, J. Clin. Pharmacol. Ther. 1965, 6, 303.
6. Grosshans, E.; Illy, G. Int. J. Dermatol. 1984, 23, 598.
7. (a) Kruse, F. E.; Joussen, A. M.; Rohrschneider, K.; Becker, M. D.; Volcker, H. E. Graefe's Arch. Clin. Exp. Ophthalmol. 1998, 236, 6, 461.
8. (b) D'Amato, R. J.; Loughnan, M. S.; Flynn, E.; Folkman, J. Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (9), 4082.
9. Rajkumar, S. V.; Dispenzieri, A.; Fonseca, R.; Lacy, M. Q.; Geyer, S.; Lust, J. A.; Kyle, R. A.; Greipp, P. R.; Gertz, M. A.; Witzig, T. E. Leukemia 2001, 15, 8, 1274.
10. Singhal, S.; Mehta, J. Biomed. Pharmacother. 2002, 56, 4.
11. Eisen, T.; Boshoff, C.; Mak, I.; Sapunar, F.; Vaughan, M. M.; Pyle, L.; Johnston, S. R. D.; Ahern, R.; Smith, I. E.; Gore, M. E. Br. J. Cancer 2000, 82 (4), 812.
12. (a) Eriksson, T.; Bjorkman, S.; Roth, B.; Fyge, A. Hoglund, P. Chirality 1996, 7, 44.
13. (b) Wintersk, W.; Frankus, E. Lancet 1992, 339, 365.
14. (a) Wnendt, S.; Finkam, M.; Winter, W.; Ossing, J.; Rabbe, G.; Zwingenberger, K. Chirality 1996, 8, 390.
15. (b) Knoche, B.; Blaschke, G. J. Chromatogr. 1994, 2, 183.
16. For examples utilizing taxol photoaffinity analogues, see: (a) Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. J. Med. Chem. 1994, 37, 2976. (b) Swindell, C. S.; Heerding, J. M.; Krauss, N. E. J. Med. Chem. 1994, 37, 1446.
17. For examples utilizing taxol photoaffinity analogues, see: (a) Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. J. Med. Chem. 1994, 37, 2976. (b) Swindell, C. S.; Heerding, J. M.; Krauss, N. E. J. Med. Chem. 1994, 37, 1446.
18. Turk, B. E.; Jiang, H.; Liu, J. O. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7552.
19. (a) Muller, G. W.; Konnecke, W. E.; Smith, A. M.; Khetani, V. D. Org. Process Res. Dev. 1999, 3, 139.
20. 3-OH).
21. Muller, G. W.; Chen, R.; Huang, S.-Y.; Corral, L. G.; Wong, L. M.; Patterson, R. T.; Chen, Y.; Kaplan, G.; Stirling, D. I. Bio. Med. Chem. Lett. 1999, 9, 1625.
22. VEGF is a known stimulator of endothelial cell proliferation.
23. (a) Reist, M.; Carrupt, P. A.; Francotte, E.; Testa, B. Chem. Res. Toxicol. 1998, 11, 1521.
24. (b) Richardson, P.; Hideshima, T.; Anderson, K. Annu. Rev. Med. 2002, 53, 629.
25. (c) Kenyon, B. M.; Browne, F.; D'Amato, R. J. Exp. Eye Res. 1997, 64, 971.
26. For examples, see: (a) Shimazawa, R.; Miyachi, H.; Takayama, H.; Kuroda, K.; Kato, F.; Kato, M.; Hashimoto, Y. Biol. Pharm. Bull. 1999, 22, 2, 224. (b) Lima, L. M.; Castro, P.; Machado, A. L.; Fraga, C. A. M.; Lugnier, C.; Goncalves de Moraes, V. L.; Barreiro, E. J. Bioorg. Med. Chem. 2002, 10, 3067.
27. For examples, see: (a) Shimazawa, R.; Miyachi, H.; Takayama, H.; Kuroda, K.; Kato, F.; Kato, M.; Hashimoto, Y. Biol. Pharm. Bull. 1999, 22, 2, 224. (b) Lima, L. M.; Castro, P.; Machado, A. L.; Fraga, C. A. M.; Lugnier, C.; Goncalves de Moraes, V. L.; Barreiro, E. J. Bioorg. Med. Chem. 2002, 10, 3067.